Tirzepatida (tirzepatide) en la prctica clnica resume en un solo artculo todo lo que el cardilogo, endocrinlogo, nefrlogo e internista necesita para integrar este agonista dual GIP/GLP-1 en su consulta: desde las indicaciones aprobadas y la pauta de dosificacin hasta la evidencia de los programas SURMOUNT, SURPASS-CVOT y SUMMIT
Since on DXA the liver is considered lean mass and the liver mass decreased up to 50% with dual agonists, this could explain the 40% lean mass loss number from human trials
By combining GLP-1, GIP, and glucagon receptor agonism, retatrutide simultaneously reduces energy intake, increases energy expenditure, and corrects insulin resistance and lipid flux
Nauck et al., 2026)
Sonic hedgehog (Shh) is co-expressed and involved in placode formation and taste cell differentiation at least in fungiform papillae [5960]
1 Originally FDA-approved for type 2 diabetes, GLP-1 RAs also lead to sustained weight loss and have revolutionized diabetes and obesity management